Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

More antiplatelet agents from Thomae

April 19, 1996

Antiplatelet agents emerging from the Thomae pipeline

April 19, 1996

New series of thrombin inhibitors claimed by Thomae

April 19, 1996

SKB discloses NK3 antagonists in patent literature

April 19, 1996

Nikken Chemicals describes antiallergy agents

April 19, 1996

Abbott claims new 5-LO inhibitors

April 19, 1996

Two novel series of LTB4 antagonists from Boehringer Ingelheim

April 19, 1996

Leukotriene D4 antagonists reported by Leo Denmark

April 19, 1996

SKB reports calcium antagonists for stroke

April 19, 1996

New Takeda compounds suppress increased vascular permeability

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.